PH24431A - Anti-retroviral castanospermine esters - Google Patents

Anti-retroviral castanospermine esters

Info

Publication number
PH24431A
PH24431A PH37614A PH37614A PH24431A PH 24431 A PH24431 A PH 24431A PH 37614 A PH37614 A PH 37614A PH 37614 A PH37614 A PH 37614A PH 24431 A PH24431 A PH 24431A
Authority
PH
Philippines
Prior art keywords
retroviral
castanospermine esters
castanospermine
esters
aids
Prior art date
Application number
PH37614A
Other languages
English (en)
Inventor
Paul S Liu
Sai Prasad Suncara
Terry L Bowlin
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of PH24431A publication Critical patent/PH24431A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH37614A 1987-09-29 1988-09-29 Anti-retroviral castanospermine esters PH24431A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/102,070 US5004746A (en) 1987-09-29 1987-09-29 Anti-retroviral castanospermine esters

Publications (1)

Publication Number Publication Date
PH24431A true PH24431A (en) 1990-06-25

Family

ID=22287973

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37614A PH24431A (en) 1987-09-29 1988-09-29 Anti-retroviral castanospermine esters

Country Status (12)

Country Link
US (1) US5004746A (de)
EP (1) EP0309952B1 (de)
JP (1) JP2761898B2 (de)
KR (1) KR960009416B1 (de)
AT (1) ATE107506T1 (de)
AU (1) AU614993B2 (de)
DE (1) DE3850335T2 (de)
DK (1) DK172788B1 (de)
ES (1) ES2058201T3 (de)
IE (1) IE64311B1 (de)
PH (1) PH24431A (de)
ZA (1) ZA887160B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650377T2 (de) * 1985-12-23 1996-02-22 Hutchinson Fred Cancer Res Regulierung der retroviralen replikation, infektion und pathogenese.
US4952585A (en) * 1988-12-15 1990-08-28 Merrell Dow Pharmaceuticals Inc. Castanospermine esters in the inhibition of tumor metastasis
US5214050A (en) * 1989-10-17 1993-05-25 Merrell Dow Pharmaceuticals Inc. Esters of castanospermine in the treatment of cerebral malaria
ZA908134B (en) * 1989-10-17 1991-07-31 Merrell Dow Pharma Esters of castanosperime in the treatment of cerebral malaria
GB8924292D0 (en) * 1989-10-27 1989-12-13 Novalal Ltd The production of a novel dimer chemical product"novo dimers"by the polymersation of indolizidine alkaloids using cyclo dextrin glucosyl transferase
US5028614A (en) * 1990-03-30 1991-07-02 Merrell Dow Pharmaceuticals Inc. Hydroxymethyl-indolizidines and quinolizidines and their use as α-glucosidase I inhibitors
GB9027433D0 (en) * 1990-12-18 1991-02-06 Merrell Dow Pharma Anti-herpes castanospermine esters
US5939430A (en) * 1993-02-22 1999-08-17 Merrell Pharmaceuticals Inc. Combinations of retroviral inhibitors
GB9303518D0 (en) * 1993-02-22 1993-04-07 Merrell Dow Pharma Combinations of retroviral inhibitors
US5959111A (en) * 1997-05-22 1999-09-28 Hoechst Marion Roussel, Inc. Process for preparing 6-0-monoesters of castanospermine
AU739675B2 (en) * 1997-05-22 2001-10-18 Aventisub Ii Inc. Process for preparing 6-O-monoesters of castanospermine
GB0110832D0 (en) * 2001-05-03 2001-06-27 Virogen Ltd Antiviral compounds
CA2576425A1 (en) * 2004-08-13 2006-08-17 Migenix Inc. Compositions and methods for treating or preventing hepadnaviridae infection
AU2005291804A1 (en) * 2004-10-06 2006-04-13 Migenix Inc. Combination anti-viral compositions comprising castanospermine and methods of use
JP2009545621A (ja) * 2006-08-02 2009-12-24 ユナイテッド セラピューティクス コーポレーション ウィルス感染症のリポソーム処置
CN102046151A (zh) * 2008-03-26 2011-05-04 牛津大学 靶向内质网的脂质体
KR20120059447A (ko) * 2009-03-27 2012-06-08 더 챈슬러 마스터즈 앤드 스칼라스 오브 더 유니버시티 오브 옥스포드 콜레스테롤 수준 저하 리포좀
EP4106752A4 (de) 2020-02-21 2024-03-20 Florida State University Research Foundation, Inc. Behandlung von infektionen mit dem humanen coronavirus unter verwendung von alpha-glucosidase-glykoprotein-prozessierungsinhibitoren

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650377T2 (de) * 1985-12-23 1996-02-22 Hutchinson Fred Cancer Res Regulierung der retroviralen replikation, infektion und pathogenese.
ZA883925B (en) * 1987-06-08 1989-02-22 Merrell Dow Pharma Inhibitors of glycoprotein processing having anti-retroviral activity
CA1315276C (en) * 1987-07-02 1993-03-30 Paul S. Liu Castanospermine esters and glycosides
US4952585A (en) * 1988-12-15 1990-08-28 Merrell Dow Pharmaceuticals Inc. Castanospermine esters in the inhibition of tumor metastasis

Also Published As

Publication number Publication date
EP0309952B1 (de) 1994-06-22
EP0309952A3 (en) 1990-09-26
EP0309952A2 (de) 1989-04-05
DE3850335T2 (de) 1994-10-13
IE64311B1 (en) 1995-07-26
DE3850335D1 (de) 1994-07-28
ZA887160B (en) 1989-05-30
ATE107506T1 (de) 1994-07-15
JP2761898B2 (ja) 1998-06-04
AU614993B2 (en) 1991-09-19
AU2280288A (en) 1989-04-06
IE882933L (en) 1989-03-29
KR960009416B1 (en) 1996-07-19
US5004746A (en) 1991-04-02
JPH01106821A (ja) 1989-04-24
DK538888A (da) 1989-03-30
DK538888D0 (da) 1988-09-28
ES2058201T3 (es) 1994-11-01
DK172788B1 (da) 1999-07-19
KR890004701A (ko) 1989-05-09

Similar Documents

Publication Publication Date Title
KR960009416B1 (en) Anti-retroviral castanospermine esters
DK441786A (da) Nucleosider, der kan anvendes terapeutisk
GB2204237B (en) Agents for the prophylaxis and therapy of retroviral infections
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
GR3006366T3 (de)
EP0295538A3 (de) Inhibitoren der Glykoprotein-Verarbeitung mit anti-retroviraler Aktivität
AU4426289A (en) Methods for interfering with hiv multiplication and composition for the treatment of aids
ATE126435T1 (de) Antiherpes-castanosperminester.
GB2206113B (en) 6-substituted penem esters as anti-inflammatory and anti-degenerative agents
FR2617182B1 (fr) Compositions concentrees et leur utilisation comme stabilisants pour des bains alcalins aux peroxydes
FI851365A0 (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
DE69015411D1 (de) 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one und -thione und deren Verwendung bei der Vorbeugung und und Behandlung von AIDS.
OA09507A (en) Compositions and methods for treating or preventing AIDS ARC and HIV infection
JPS6452781A (en) Novel antitumoral and antiviral composition from mrine source
AU1792788A (en) Rubradirin derivatives for treatment of hiv infection
AU98542S (en) Bat
ZA896430B (en) Hiv protease inhibitors useful for the treatment of aids
PH25193A (en) Method and composition for the prophylaxis and treatment of retroviral infection